Skip to main content
. Author manuscript; available in PMC: 2016 Jun 29.
Published in final edited form as: Eur J Radiol. 2015 Mar 14;84(6):1171–1176. doi: 10.1016/j.ejrad.2015.02.030

Table 2. Multivariable association with pathological T stage.

Imaging Biomarker T Stage =T3/T41
OR (95% CI)
PET/CT
ring/heterogeneous pattern (yes vs. no)		 4.23 (0.98-18.30)
CECT
high/heterogeneous pattern (yes vs. no)		 9.17 (1.54-54.62)
Tumor PET/CT parameters:
 SUV max
(high vs. low)		 6.34 (1.38-29.02)
 SUV mean
(high vs. low)		 6.34 (1.38-29.02)*
 SUV peak
(high vs. low)		 3.74(0.89-15.74)
 MTV
(high vs. low)		 18.98 (3.25-110.8)*
 TLG
(high vs. low)		 18.98 (3.25-110.8)
 N SAM
(high vs. low)		 18.98 (3.25-110.8)*
 SAM
(high vs. low)		 11.7 (2.2-82.2)
Nodal PET/CT Parameters (yes vs. no) 3.87 (0.82-18.2)

OR, Odds ratios; CI, confidence interval; SUV, standardized uptake values; MTV, metabolic tumor volume; TLG, total lesion glycolysis; N SAM, normalized standardized added metabolic activity; SAM, standardized added metabolic activity.

*

P-value < 0.05.

1

Adjusted for smoking. N=30 for CECT ring/heterogeneous pattern model; N=36 for all other models